The latter function is performed by the islets of Langerhans, cells in the pancreas (named after their discoverer, ...

Funding This work was supported by The Children’s Discovery Institute of Washington University and St. Louis Children’s Hospital MI-II-2018-750-2, NIH/NIDDK R01 DK128188 to XX and by NIH/NIDDK R01 ...

Novel analogues of the P2 receptor antagonist pyridoxal-5‘-phosphate 6-azophenyl-2‘,5‘-disulfonate (2) were synthesized and studied as antagonists in functional assays at recombinant rat P2X1, P2X2, ...

The PALF Study Group is supported by NIH-NIDDK 1 U01 DK072146-01.

Cardiovascular disease risk factor control as primary prevention in patients with type 2 diabetes mellitus has changed substantially in the past few years. The purpose of this scientific statement is ...

Once-daily fixed-ratio combination therapies of basal insulin and a GLP-1 receptor agonist such as insulin degludec with liraglutide (IDegLira) and insulin glargine U100 with lixisenatide (IGlarLixi) ...

NIH/NIDDK R01: Effects of GLP-1 receptor agonists on cardiometabolic alteration in HIV-associated lipohypertrophy PCORI: Comparing the Effectiveness of Fatigue Management Programs for People with MS ...